Login / Signup

A patent review of adenosine A 2B receptor antagonists (2016-present).

Beatrice FrancucciDiego Dal BenCatia LambertucciAndrea SpinaciRosaria VolpiniGabriella MarucciMichela Buccioni
Published in: Expert opinion on therapeutic patents (2022)
ARs drugs. Although several compounds have been synthesized only a few molecules have entered clinical trials.
Keyphrases
  • clinical trial
  • protein kinase
  • phase ii
  • randomized controlled trial
  • open label
  • drug induced
  • double blind